Donald Olds has been appointed chief operating officer at Bioniche Life Sciences. Prior to joining the company, Mr. Olds held key executive positions in biotechnology, investment banking, biotechnology and IT, and has led successful licensing, merger and acquisition and debt and equity transactions. He currently serves as chairman of the board of the Neomed Institute, director and chair of the Audit Committee of the Centre Quebecois, director of Bellus Health, and is treasurer of Oxfam Quebec.
Dr. Michael Berendt, chief executive officer of Bioniche Life Sciences Inc., said, "The engagement of Donald Olds is the next step in our operational plan to position Bioniche Life Sciences as a top-tier North American biotechnology company with a focus on the development of oncology therapeutics. Don brings a rare combination of scientific, operational, and financial acumen that we are confident will help us position our human therapeutic business for future success and permit us to achieve our other operational objectives, including the licensing and divestiture of our non-core business assets and the implementation of operating cost reductions."